Toronto, ON - April 19, 2018 - (Newswire.com)
One important aspect of the U.S. Food and Drug Administration’s (FDA) traceability legislation, the Drug Supply Chain Safety Act (DSCSA), is a requirement that by 2023, all prescription drugs be tracked and traced through the supply chain using an interoperable system. While existing serialization and traceability solutions meet the current DSCSA regulations, there is no system in place that is fully interoperable at this time.
The FDA is looking to the pharma industry to develop its own solution for complete interoperability. There is currently work underway to demonstrate the viability of various blockchain solutions for pharma supply chains that has broad participation from the pharma industry, solution providers and regulatory agencies.
The goal of this live webinar is to get you up to speed on that work, as well as share how one global technology company envisions developing blockchain solutions for the pharma industry in the near future.
Bob Celeste, Founder of The Center for Supply Chain Studies (CSCS) will share information/progress about the center’s proof-of-concept pilot program, “DSCSA and blockchain, phase 2.” During this webinar, Bob will provide an update for people who aren’t able to be part of the April 30 – May 1 in-person meetings where teams will perform walkthroughs of their work studies. This webinar will also be helpful to those who attended that event and want a summary or refresher on what ground was covered and what will likely take place next.
OPTEL has long believed that incorporating blockchain into its serialization and traceability solutions for its pharma customers will offer them the greatest value. Jean Pierre Allard, Chief Technology Officer at OPTEL, will outline the company’s vision and its core development beliefs for blockchain technology; namely, that future blockchain solutions should be industry-specific and vendor-agnostic. He will share the company’s overarching compatibility goals that aim to support blockchain efforts industry-wide, as well as provide insights into how OPTEL hopes to offer integration points and expanded services to all blockchains so that one blockchain can be adopted by the entire pharmaceutical industry.
There will be time for questions and answers following Bob and JP’s presentations.
Join this complimentary webinar on Wednesday, May 9, 2018 at 1pm EDT. For more information or to register for this event visit: Understanding the Impact of Blockchain on Pharmaceutical Serialization and Track & Trace Requirements.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Nima Rajan
Tel: +1 (416) 977-6555 ext 352
Email: nrajan@xtalks.com
Related Links
Webinar Details
About OPTEL
Related Images
Press Release Service by Newswire.com
Original Source: Understanding the Impact of Blockchain on Pharmaceutical Serialization and Track & Trace Requirements, New Webinar Hosted by Xtalks
